European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN
Jean‐Yves Blay, Paolo G. Casali, Corinne Bouvier, Caroline Dehais, Iain Galloway, Jourik A. Gietema, Jana Halámková, Nadia Hindi, Ahmed Idbaïh, Emma Kinloch, H.-J. Klümpen, Teodora Kolarova, Kateřina Kopečková, József Lövey, Manuel Pedro Magalhães, Kersti Oselin, Sophie Piperno‐Neumann, A. Ravnsbaek, Muriel Rogasik, Akmal Safwat, Susanne Scheipl, Michael J. Seckl, Jane R. Taylor, M. Temnyk, Annalisa Trama, Mindaugas Urbonas, Markus Wartenberg, A. Weinman
Abstract
The standard definition of ‘rare cancer’ is a malignant disorder with an incidence of <6 per 100 000 per year according to the Surveillance of Rare Cancers in Europe (RARECARE), with a wide variety of incidence for the different rare cancers.
Topics & Concepts
Position statementIncidence (geometry)Member statesMedicineCancerPosition (finance)Statement (logic)Health carePediatricsFamily medicineEuropean unionPolitical scienceInternal medicineBusinessInternational tradeLawOpticsFinancePhysicsSarcoma Diagnosis and TreatmentCancer Diagnosis and TreatmentTumors and Oncological Cases